Patents Assigned to Galderma S.A.
  • METHOD OF TREATING HEMORRHOIDS USING MACROCYCLIC LACTONE COMPOUND
    Publication number: 20130178433
    Abstract: A method of treating hemorrhoids is disclosed. The method includes locally administering a composition including an effective amount of one or more macrocyclic lactone compounds, including avermectin compounds, milbemycin compounds, or mixture thereof and a pharmaceutically acceptable carrier to the affected anorectal region of an individual suffering from hemorrhoid.
    Type: Application
    Filed: October 14, 2011
    Publication date: July 11, 2013
    Applicant: GALDERMA S.A.
    Inventors: L. Dean Parks, Jeffrey D. Parks
  • METHOD OF TREATING HERPES VIRUS INFECTION USING MACROCYCLIC LACTONE COMPOUND
    Publication number: 20130172282
    Abstract: A method of treating herpes simplex virus infection or varicella zoster virus infection is disclosed. The method includes topically applying a composition containing an effective amount of one or more macrocyclic lactone compounds, including avermectin compounds or milbemycin compounds and a pharmaceutically acceptable carrier to the affected area of an individual suffering from herpes simplex virus infection or varicella zoster virus infection.
    Type: Application
    Filed: October 14, 2011
    Publication date: July 4, 2013
    Applicant: GALDERMA S.A.
    Inventors: L. Dean Parks, Jeffrey D. Parks
  • Topical application of ivermectin for the treatment of dermatological conditions/afflictions
    Patent number: 8470788
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: June 25, 2013
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES
    Publication number: 20130109642
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Application
    Filed: December 17, 2012
    Publication date: May 2, 2013
    Applicant: Galderma S.A.
    Inventor: Galderma S.A.
  • COMPOSITIONS COMPRISING AT LEAST ONE AQUEOUS PHASE AND AT LEAST ONE FATTY PHASE WHICH COMPRISES AVERMECTIN COMPOUNDS
    Publication number: 20130108563
    Abstract: Pharmaceutical/dermatological emulsions containing at least one avermectin compound, notably ivermectin, include at least one fatty phase and at least one aqueous phase, the at least one avermectin compound being solubilized in the fatty phase, which emulsions are useful for the treatment of a variety of dermatological conditions/afflictions, in particular rosacea.
    Type: Application
    Filed: December 19, 2012
    Publication date: May 2, 2013
    Applicant: Galderma S.A.
    Inventor: Galderma S.A.
  • AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
    Publication number: 20130095051
    Abstract: Pharmaceutical/dermatological compositions containing at least one avermectin compound, e.g., ivermectin and metronidazole or salt, ester or derivative thereof, are useful for treating afflictions of the skin, especially rosacea.
    Type: Application
    Filed: December 6, 2012
    Publication date: April 18, 2013
    Applicant: GALDERMA S.A.
    Inventor: Galderma S.A.
  • Topical application of ivermectin for the treatment of dermatological conditions/afflictions
    Patent number: 8415311
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: April 9, 2013
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • COMPOSITIONS COMPRISING AVERMECTIN/AZELAIC ACID COMPOUNDS USEFUL FOR TREATING E.G., ROSACEA
    Publication number: 20130064780
    Abstract: Pharmaceutical/dermatological compositions useful for the prevention/treatment of disorders of the skin, especially rosacea, contain thus effective amounts of at least one avermectin compound, e.g., ivermectin, and at least one azelaic acid compound or salt or derivative thereof, formulated into a physiologically acceptable medium therefor.
    Type: Application
    Filed: March 1, 2012
    Publication date: March 14, 2013
    Applicant: Galderma S.A.
    Inventors: Alexandre KAOUKHOV, Colette PERNIN
  • DERMATOLOGICAL COMPOSITIONS COMPRISING AVERMECTIN NANOCAPSULES
    Publication number: 20130034612
    Abstract: Compositions and nanoemulsions containing lipid nanocapsules dispersed in a hydrophilic phase, such nanocapsules including at least one avermectin compound, are useful for the treatment of dermatological pathologies, e.g., rosacea.
    Type: Application
    Filed: October 9, 2012
    Publication date: February 7, 2013
    Applicant: GALDERMA S.A.
    Inventor: Galderma S.A.
  • Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
    Patent number: 8361974
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: January 29, 2013
    Assignee: Galderma S.A.
    Inventors: Alexandre Kaoukhov, Christophe Villard, Philippe Bouissou
  • Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds
    Patent number: 8362069
    Abstract: Pharmaceutical/dermatological emulsions containing at least one avermectin compound, notably ivermectin, include at least one fatty phase and at least one aqueous phase, the at least one avermectin compound being solubilized in the fatty phase, which emulsions are useful for the treatment of a variety of dermatological conditions/afflictions, in particular rosacea.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: January 29, 2013
    Assignee: Galderma S.A.
    Inventors: Fanny Diaz-Astruc, Nathalie Barthez, Sandrine Segura-Orsoni
  • PETROLEUM JELLY-FREE UNGUENT COMPOSITIONS COMPRISING VITAMIN D COMPOUNDS AND OPTIONALLY STEROIDAL ANTI-INFLAMMATORY AGENTS
    Publication number: 20130012484
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: GALDERMA S.A.
    Inventors: Nathalie WILLCOX, Nathalie BARTHEZ, Karine NADAU-FOURCADE, Claire MALLARD
  • Dermatological compositions comprising avermectin nanocapsules
    Patent number: 8309121
    Abstract: Compositions and nanoemulsions containing lipid nanocapsules dispersed in a hydrophilic phase, such nanocapsules including at least one avermectin compound, are useful for the treatment of dermatological pathologies, e.g., rosacea.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: November 13, 2012
    Assignee: Galderma S.A.
    Inventors: Lara Baudonnet, Claire Mallard
  • TOPICAL SKIN CARE COMPOSITION
    Publication number: 20120263666
    Abstract: A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.
    Type: Application
    Filed: June 26, 2012
    Publication date: October 18, 2012
    Applicant: GALDERMA S.A.
    Inventors: Nancy Puglia, Jerry Roth, Rosario Ramirez
  • Inverse emulsions comprising avermectins and cosmetic/dermatological applications thereof
    Patent number: 8287891
    Abstract: Physically and chemically stable, oxidation-resistant, cosmetic/dermatological inverse emulsions contain a therapeutically effective amount of at least one avermectin compound, notably ivermectin, a glycolic or aqueous/glycolic dispersed hydrophilic phase, a continuous lipophilic phase and an emulsifier having an HLB ranging from 2 and 7, and are useful for the treatment of a variety of dermatological conditions/afflictions, e.g., rosacea.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: October 16, 2012
    Assignee: Galderma S.A.
    Inventors: Sandrine Segura-Orsoni, Fanny Diaz-Astruc
  • TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS
    Publication number: 20120258062
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: June 21, 2012
    Publication date: October 11, 2012
    Applicant: Galderma S.A.
    Inventors: Vincent MANETTA, Gary R. Watkins
  • Topical skin care composition
    Patent number: 8247395
    Abstract: A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: August 21, 2012
    Assignee: Galderma S.A.
    Inventors: Nancy Puglia, Jerry Roth, Rosario Ramirez
  • Production of bepromoline
    Patent number: 8242268
    Abstract: A process for the preparation of a compound of formula (Ib): including contacting a compound of formula (Ia): with toluene and HCl gas to provide the compound of formula (Ib).
    Type: Grant
    Filed: August 17, 2010
    Date of Patent: August 14, 2012
    Assignee: Galderma S.A.
    Inventors: Beat Weber, Stefan Rosenberger
  • Sustained-Release Tablet and Process for Preparing the Same
    Publication number: 20120100214
    Abstract: A method for producing a sustained-release tablet having improved stability and content uniformity is provided. The method involves first preparing a core tablet by granulating, drying, milling, blending, and compressing a mixture of active and inactive ingredients. Four coating layers are applied to the core tablet: an inner layer, an enteric coating layer, an active layer, and an outer layer. The active ingredient may be a tetracycline, such as doxycycline. A sustained-release tablet prepared according to the method is also described.
    Type: Application
    Filed: October 21, 2011
    Publication date: April 26, 2012
    Applicant: Galderma S.A.
    Inventors: Sandrine SEGURA, Ludovic BUSSARD, Jean-Pierre ETCHEGARAY
  • TOPICAL GEL COMPOSITIONS AND METHODS OF USE
    Publication number: 20120101104
    Abstract: Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and paraben, and are substantially free of paraben crystalline particles after an extended period of storage.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 26, 2012
    Applicant: GALDERMA S.A.
    Inventors: Jean-Christophe BUGE, Karine NADAU-FOURCADE, Cyril MEUNIER